Literature DB >> 10708454

Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism.

K D Ryman1, W B Klimstra, K B Nguyen, C A Biron, R E Johnston.   

Abstract

Infection of adult 129 Sv/Ev mice with consensus Sindbis virus strain TR339 is subclinical due to an inherent restriction in early virus replication and viremic dissemination. By comparing the pathogenesis of TR339 in 129 Sv/Ev mice and alpha/beta interferon receptor null (IFN-alpha/betaR(-/-)) mice, we have assessed the contribution of IFN-alpha/beta in restricting virus replication and spread and in determining cell and tissue tropism. In adult 129 Sv/Ev mice, subcutaneous inoculation with 100 PFU of TR339 led to extremely low-level virus replication and viremia, with clearance under way by 96 h postinoculation (p.i.). In striking contrast, adult IFN-alpha/betaR(-/-) mice inoculated subcutaneously with 100 PFU of TR339 succumbed to the infection within 84 h. By 24 h p.i. a high-titer serum viremia had seeded infectious virus systemically, coincident with the systemic induction of the proinflammatory cytokines interleukin-12 (IL-12) p40, IFN-gamma, tumor necrosis factor alpha, and IL-6. Replicating virus was located in macrophage-dendritic cell (DC)-like cells at 24 h p.i. in the draining lymph node and in the splenic marginal zone. By 72 h p.i. virus replication was widespread in macrophage-DC-like cells in the spleen, liver, lung, thymus, and kidney and in fibroblast-connective tissue and periosteum, with sporadic neuroinvasion. IFN-alpha/beta-mediated restriction of TR339 infection was mimicked in vitro in peritoneal exudate cells from 129 Sv/Ev versus IFN-alpha/betaR(-/-) mice. Thus, IFN-alpha/beta protects the normal adult host from viral infection by rapidly conferring an antiviral state on otherwise permissive cell types, both locally and systemically. Ablation of the IFN-alpha/beta system alters the apparent cell and tissue tropism of the virus and renders macrophage-DC-lineage cells permissive to infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708454      PMCID: PMC111838          DOI: 10.1128/jvi.74.7.3366-3378.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Mechanism of altered Sindbis virus neurovirulence associated with a single-amino-acid change in the E2 Glycoprotein.

Authors:  P C Tucker; D E Griffin
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection.

Authors:  L P Cousens; J S Orange; H C Su; C A Biron
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  Age-dependent resistance of mice to sindbis virus infection: reticuloendothelial role.

Authors:  S A Hackbarth; A B Reinarz; B P Sagik
Journal:  J Reticuloendothel Soc       Date:  1973-11

4.  Deduced consensus sequence of Sindbis virus strain AR339: mutations contained in laboratory strains which affect cell culture and in vivo phenotypes.

Authors:  K L McKnight; D A Simpson; S C Lin; T A Knott; J M Polo; D F Pence; D B Johannsen; H W Heidner; N L Davis; R E Johnston
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  The course of Semliki Forest virus infection in mice.

Authors:  J Seamer; W J Randles; R Fitzgeorge
Journal:  Br J Exp Pathol       Date:  1967-08

6.  Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step.

Authors:  A S Morel; S Quaratino; D C Douek; M Londei
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

7.  Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-alpha/beta.

Authors:  K Sandberg; P Kemper; A Stalder; J Zhang; M V Hobbs; J L Whitton; I L Campbell
Journal:  J Immunol       Date:  1994-07-01       Impact factor: 5.422

8.  High-dose interferon-gamma alters the distribution of B lymphocytes and macrophages in rat spleen and lymph nodes.

Authors:  B Steiniger; P H van der Meide
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

9.  Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.

Authors:  F B Grieder; N L Davis; J F Aronson; P C Charles; D C Sellon; K Suzuki; R E Johnston
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

10.  Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection.

Authors:  M C Ruzek; A H Miller; S M Opal; B D Pearce; C A Biron
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

View more
  119 in total

1.  Biologic consequences of Stat1-independent IFN signaling.

Authors:  M P Gil; E Bohn; A K O'Guin; C V Ramana; B Levine; G R Stark; H W Virgin; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

2.  Manipulation of host factors optimizes the pathogenesis of western equine encephalitis virus infections in mice for antiviral drug development.

Authors:  Pennelope K Blakely; Phillip C Delekta; David J Miller; David N Irani
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

3.  Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.

Authors:  Christina L Gardner; Crystal W Burke; Stephen T Higgs; William B Klimstra; Kate D Ryman
Journal:  Virology       Date:  2012-02-01       Impact factor: 3.616

4.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

5.  Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Authors:  Karine Labadie; Thibaut Larcher; Christophe Joubert; Abdelkrim Mannioui; Benoit Delache; Patricia Brochard; Lydie Guigand; Laurence Dubreil; Pierre Lebon; Bernard Verrier; Xavier de Lamballerie; Andreas Suhrbier; Yan Cherel; Roger Le Grand; Pierre Roques
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

6.  Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling.

Authors:  Rebeca Burdeinick-Kerr; Dhanasekaran Govindarajan; Diane E Griffin
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.

Authors:  Silvia Perri; Catherine E Greer; Kent Thudium; Barbara Doe; Harold Legg; Hong Liu; Raul E Romero; Zequn Tang; Qian Bin; Thomas W Dubensky; Michael Vajdy; Gillis R Otten; John M Polo
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus.

Authors:  Patricia V Aguilar; Slobodan Paessler; Anne-Sophie Carrara; Samuel Baron; Joyce Poast; Eryu Wang; Abelardo C Moncayo; Michael Anishchenko; Douglas Watts; Robert B Tesh; Scott C Weaver
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice.

Authors:  Kristina S Burrack; Stephanie A Montgomery; Dirk Homann; Thomas E Morrison
Journal:  J Immunol       Date:  2014-12-08       Impact factor: 5.422

10.  A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads.

Authors:  Tyler R Prestwood; Daniil M Prigozhin; Kristin L Sharar; Raphaël M Zellweger; Sujan Shresta
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.